ADC Pipeline Analysis Report: Drugs & Development 2026

добавлена новая статья Health

2026-01-21 11:15:24 -

What are antibody-drug conjugates, and why are they important in oncology pipelines? Antibody-drug conjugates (ADCs) are innovative cancer therapies that combine monoclonal antibodies with cytotoxic drugs. They specifically target tumor-associated antigens, delivering potent agents directly to cancer cells while minimizing damage to healthy tissue. As the global cancer burden is projected to...

0 Комментарии 0 Поделились 27 Просмотры 0 предпросмотр